A phase I/II trial of liposomal doxorubicin (tlc-d99, myocet) in combination with cyclophosphamide, vincristine, and prednisone (comp) for newly diagnosed intermediate and high grade non-Hodgkin's lymphoma (nhl)

✍ Scribed by A. Tulpule; B.M. Espina; N. Berman; L.H. Buchanan; W.D. Boswell; L. Welles; A.M. Levine

• Book ID: 117658190
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 180 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80821-2